See the DrugPatentWatch profile for Umeclidinium
The price of umeclidinium can vary significantly depending on factors such as the specific product formulation, dosage, quantity, and the pharmacy or retailer. Umeclidinium is often prescribed in combination with other medications for the treatment of chronic obstructive pulmonary disease (COPD) [1].
How much does umeclidinium cost?
Without insurance, a prescription for umeclidinium can range from approximately $150 to over $300 for a 30-day supply. For example, a 30-day supply of umeclidinium bromide inhalation powder, 62.5 mcg, might cost around $250 without insurance [2]. Prices can differ between pharmacies.
Can I get a discount on umeclidinium?
Discount programs and coupons can help reduce the out-of-pocket cost of umeclidinium. Pharmaceutical manufacturers sometimes offer savings cards or coupons for their branded medications, which can lower the price for eligible patients [3]. Online pharmacies or discount prescription programs may also offer lower prices.
How does insurance affect umeclidinium cost?
Insurance coverage for umeclidinium varies by plan. Many insurance providers cover umeclidinium, but the patient's copay or coinsurance will depend on their specific health insurance policy. Some plans may require prior authorization before covering the medication [2].
What is umeclidinium used for?
Umeclidinium is a long-acting muscarinic antagonist (LAMA) used to treat COPD, including chronic bronchitis and emphysema [1]. It is often available in combination inhalers, such as with vilanterol (e.g., Anoro Ellipta) or with fluticasone furoate and vilanterol (e.g., Trelegy Ellipta), which also treat asthma [4].
When does umeclidinium patent expire?
Information on specific patent expiry dates for umeclidinium and its combination products is available through resources like DrugPatentWatch.com [5]. Patents provide market exclusivity for a period, after which generic versions may become available, potentially lowering prices.
What are alternatives to umeclidinium?
Other bronchodilators, including other LAMAs, long-acting beta-agonists (LABAs), and combination inhalers, are available for COPD treatment. Examples include tiotropium, salmeterol, and aclidinium. The choice of medication depends on individual patient needs, physician recommendations, and treatment guidelines [4].
---
Sources:
1. https://medlineplus.gov/druginfo/meds/a614039.html
2. https://www.goodrx.com/umeclidinium-bromide
3. https://www.pfizer.com/health-topics/patient-support
4. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5322331/
5. https://drugpatentwatch.com/